Huhtamaki India Ltd

- Significant capex is ongoing, mostly focused on the blueloop project. - Capex additions are reflected in the balance sheet, primarily toward blueloop. - The Silvassa plant capex is substantial and commissioning is expected by Q3 or Q4. - The company plans additional investment to reach 60-65% blueloop product sales over time. - Total capex amount spent till date is significant but unspecified; more investment will be required as plans evolve. - The strategy includes investing in innovation, key account management, and sustainable packaging solutions. - Long-term capex aims to support growth and enhance competitiveness through proprietary technology and innovation.

- No explicit mention of any current or future fundraising through debt or equity was found in the provided excerpts. - The company reported a net debt of around INR 321 crores as of June, with an average coupon rate close to 8%. - Debt equity ratio is stable at around 0.4, consistent with previous quarters. - Debt-to-EBITDA ratio increased to 7.6 due to certain borrowings but some repayments were made. - Liquidity is described as strong with sizable credit lines mostly utilized at quarter-end. - Cash position and free cash flow have been impacted somewhat by higher capital expenditures. - Financial position has stabilized in the last year. - No direct disclosures or plans regarding raising new funds through debt or equity were noted in this call.

- The company has witnessed volume and top-line decline recently due to portfolio optimization and challenging market conditions, especially in personal care and beverages segments. - They are focusing on targeted categories, innovation, key account management, and value selling to drive growth. - Volume growth is expected to improve over the next 2 years from the low base of 2022. - Blueloop (sustainable products) currently contributes about 22%-25% and is targeted to increase to 60%-65% of sales by 2030, which is expected to support growth. - Capacity is being utilized strategically with optimization and consolidation of sites. - Export benefits and increased competitiveness through product innovation and cost-effectiveness are expected to contribute to revenue growth. - Overall, a gradual improvement in top-line and volume growth is anticipated as the company sharpens focus and invests in strategic products and customer partnerships.

- EBITDA margin is improving, from around 4% in 2021, to 6% in 2022, to approximately 8% in H1 2023, with expectations of further improvement. - Target EBIT margin by 2030 is 10%, indicating a long-term margin expansion strategy. - Sustainable growth is expected from innovative "blueloop" products, which currently contribute ~22-25% of sales, targeted to increase to 60-65% by 2030. - The company aims for EBIT margins of around 7%-7.5% in the near term (next 2 years), moving toward pre-COVID norms. - Net profit and EPS show year-on-year improvement: EPS at INR 6.89 for H1 2023, reflecting better bottom-line performance despite volume pressures. - Gradual volume growth is anticipated from a low base of 2022. - Continued investments in technology and operational efficiencies are expected to translate gross margin improvements into better EBITDA and net profits over time.

The transcript provided does not explicitly mention details about the current or expected order book or pending orders for Huhtamaki India Limited. However, some relevant insights related to business focus and volumes include: - The company witnessed a 15% dip in top line in H1, mainly due to volume decline linked to portfolio optimization. - They have voluntarily cut down on unprofitable business segments to focus on strategic, high-priority categories. - There is a focus on innovation, key account management, and value selling to drive future growth. - Volume growth expectations over the next 2 years were queried but no specific guidance was provided. - The company is working on improving customer relevance and positioning their blueloop sustainable product to increase business share. - Around 30% of their sales come from exports; competitive pressure remains in the domestic market. No direct figures or order book specifics were disclosed in the transcript.